BACKGROUND: People with multiple sclerosis (MS) are confronted with a number of important uncertainties concerning many aspects of the disease. Among others, these include diagnosis, prognosis, disease course, disease-modifying therapies, symptomatic therapies and non-pharmacological interventions. It has...
Malcomson KS, Dunwoody L, Lowe-Strong AS (2007) Psycho- social interventions in people with multiple sclerosis: a review. J Neurol 254:1-13K. S. Malcomson, L. Dunwoody, and A. S. Lowe-Strong, "Psychosocial interventions in people with multiple sclerosis: a review," Journal of Neurology,...
multiple sclerosisoral healthprevalence epidemiologysystematic reviewObjectives: Despite more than 25 years of research focused on this topic, it remains unclear whether people with multiple sclerosis are more likely to present with oral health problems. The aim of this study was to provide the first ...
Funding medicines for people with multiple sclerosis.Editorial. Suggests that providing outcome guarantees for some medical treatment may create new ways of funding innovative treatment programs, and focuses on multiple sclerosis. Information about the Labour Party in Britain and the establishment of the ...
Multiple sclerosis affects persons of all ages. Age is a predictor of MS phenotypes and onset of relapsing MS (RMS) between age 20 to 40 years accounts for 80% of cases. Secondary progressive MS (SPMS) is considered the long-term outcome of RMS, but more than 30% of people with M...
Access to health care for people with multiple sclerosis Although experts recommend that people with multiple sclerosis (MS) should begin treatment with disease-modifying agents (DMAs) as soon as possible after d... SL Minden,D Frankel,L Hadden,... - 《Multiple Sclerosis》 被引量: 70发表: ...
- 《Multiple Sclerosis & Related Disorders》 被引量: 0发表: 0年 Do people with multiple sclerosis want to discuss their long-term prognosis? A nationwide study in Argentina. Background: Demographics, clinical and imaging prognostic factors have been reported in large series of people with ...
Development and validation of a self-efficacy measure for people with multiple sclerosis: the Multiple Sclerosis Self-efficacy Scale. The aim of this study is to develop and validate a brief measure of self-efficacy specifically for use with people with multiple sclerosis (MS). Self-effic... S...
multiple sclerosis Palliative care interventions for people with multiple sclerosisPalliative care interventions for people with multiple sclerosisThis is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effectiveness and safety of non-invasive positive pressure...
Exercise Intervention for Multiple Sclerosis MS: Multiple sclerosis PwMS: People with multiple sclerosis RCT: Randomised controlled trial References Lindblad AS, Zingeser P, Sismanyazici-Navaie N. Incentives and barriers to neurological clinical research participation. Clin Investig (Lond). 2011;12...